英文期刊與參考書目
Bhatt, A. 2004. “Clinical Trials in India: Pangs of Globalization”. Indian Journal of Pharmacology, 36, 4: 207-208.
Brint. S., &, J. Karabel. 1991. “Institutional Origins and Transformations: The case of American Community Colleges”. In W. Powell & P. DiMaggio (Eds.). The New Institutionalism in Organizational Analysis: 337-360. Chicago: University of Chicago Press.
Bryde, David James and Joby, Roger. 2007. “Product-based planning: the importance of project and project management deliverables in the management of clinical trials”. R&D Management. Oxford. 37, 4: 363
Davis, Gerald F. and Marquis Christopher. 2005. “Prospects for Organization Theory in the Early Twenty-First Century: Institutional Fields and Mechanisms”. Organization Science 16, 4: 332-343.
Davis, Gerald F. 2006. “Mechanisms and the Theory of Organizations". Journal of Management Inquiry 15, 2:114-118.
D’Aunno, Thomas. 2005. “Management scholars and public policy: a bridge too far?” Academy of Management Journal, 48, 6:949-951.
Denzin, N. K. 1978. The research act: A theoretical introduction to sociological methods (2nd). New York: McGraw-Hill.
DiMaggio, Paul J., and Walter W. Powell, 1983. “The iron cage revisited: Institutional isomorphism and collective rationality in organizational fields”. American Sociological Review 48:147-160
Fisher, Jill. 2006. “Procedural Misconceptions and Informed Consent: Insights from Empirical Research on the Clinical Trials Industry”. Kennedy Institutes of Ethics Journal. Baltimore. 16, 3: 251-269
Fligstein, N. 1992. “Bank control, owner control or organizational dynamics: Who controls the large modern corporation?” American Journal of Sociology, 98: 280-307.
Friedland, Roger and Robert R.Alford, 1991. “Bringing society back In: Symbols, practices, and institutional contradictions”. In Walter W. Powell and Paul J. DiMaggio (Eds) The New Institutionalism in Organizational Analysis: 232-263. Chicago: University of Chicago Press.
Glickman, Seth, Mchutchison, John, Peterson, Eric and Cairns, Charles. 2009. “Ethical and Scientific Implications of the Globalization of Clinical Research”. The New England Journal of Medicine, 360, 8: 816
Janesick, V. J. 1998a. “The dance of qualitative research design: Metaphor, methodolatry, and meaning”. In N.K. Denzin & Y. S. Lincoln (Eds), Strategies of Qualitative Inquiry. Thousand Oaks, CA: Sage.
Hall, Peter A., and David Soskice. 2001a. “An introduction to varieties of capitalism”. In Peter A. Hall and David Soskice (Eds) In Varieties of Capitalism: The Institutional Foundation of Comparative Advantage: 1-68. Oxford: Oxford University Press.
Hoffman, J. Andrew. 1997. 2001. From Heresy to Dogma: An Institutional History of Corporate Environmentalism. San Francisco: New Lexington Press
Hoffman, Andrew J. 1999. “Institutional Evolution and Change: Environmentalism and the U.S. Chemical Industry”. Academy of Management Journal 42, 4: 351-371
Hsiao, Mei-Ling. 1998. “The current status of clinical trials and GCP in Taiwan”. Drug Information Journal, 32: 1203-1207.
Huckman, Robert and Zinner, Darren. 2008. “Does focus improve operational performance? Lessons from the management of clinical trials”. Strategic Management Journal. Chichester. 29, 2: 2
Karlberg, J. 2008. “The trial of sponsored clinical trials”. Clinical Trial Magnifier 1, 4:49-76
Karlberg, J. 2008. “Development of sponsored clinical trials in Asia”. Clinical Trial Magnifier 1, 5
Krasner, Stephen D. 1988. “Sovereignty: An institutional perspective”. Comparative Political Studies 21:66-94.
March, James G. 2007. “The Study of Organizations and Organizing Since 1945”. Organization Studies 28(1): 9-19. Sage.
Mello, Michelle, Clarridge, Brian and Studdert David. 2005. “Academic Medical Centers’ Standards for Clinical-Trial Agreement with Industry”. The New England Journal of Medicine. Boston. 352, 21: 2202-2210
Maxwell, Joseph A. 2005. Qualitative Research Design: An Interactive Approach. London: Sage
Meyer, John W. and B. Rowen.1997. “Institutionalized organizations: Formal structure as myth and ceremony”. American Journal of Sociology. 83: 340-63
Pierson, Paul. 2004. Politics in Time: History, Institutions, and Social Analysis. Princeton, NJ: Princeton University Press.
Pittigrew, Andrew M. 1997. “What is a processual analysis”? Scand. J. Mgmt 13, 4: 337-348.
Powell, Walter K. 1999. “The Social construction of an organizational field: the case of biotechnology”. International Journal of Biotechnology. 1, 1: 42-66.
PricewaterhouseCoopers. 2008. The changing dynamics of pharma outsourcing in Asia. New York.
Rynes, Sara L. and Debra L. Shaprio. 2005. “Academy of management journal editors’ forum. Public policy and the public interest: what if we mattered more?” Academy of Management Journal. 48, 6: 925-927.
Saillot, Jean-Louis and Paxton, Mark. 2009. “Industry Efforts on Simultaneous Global Development”. Drug Information Journal, 43, 3: 339-347.
Scott, Richard W. 1991. “Unpacking institutional arguments”. In W. Powell & P. DiMaggio (Eds.). The new institutionalism in organizational analysis: 164-182. Chicago: University of Chicago Press.
Scott, Richard W., John W. Meyer, and associates. 1994. Institutional environments and organizations: structural complexity and individualism. CA: Sage
Scott, Richard W. 1995, 2008, Institutions and organizations. Thousand Oaks: Sage
Scott, Richard W. and Søren Christensen.. 1995. “The Institutional Construction of Organizations”: International and Longitudinal Studies. Sage.
Scott, Richard W., Martin Ruef, Peter J. Mendel and Carol A. Caronna. 2000. Institutional Change and Healthcare Organizations: From Professional Dominance to Managed Care. University of Chicago Press.
Scott, Richard W. 2001, Institutions and organizations. Thousand Oaks: Sage.
Scott, Richard W. 2002. “Organizations and the natural environment: Evolving models”. In A. Hoffman and M. Ventresa (eds), Organizations, Policy, and the Natural Environment: Institutional and Strategic Perspectives: 453-464. Calif: Standford University Press.
Scott, W. Richard, 2003, Organizations: rational, natural, and open systems. Prentice Hall. (with 1981, 1987, 1992, 1998, 2003 editions)
Scott, Richard W. 2004. “Competing logics in health care: professional, state, and managerial”. The sociology of the economy, Frank Dobbin (Ed), 267-287, New York: Russell Sage Foundation
Scott, Richard W. 2005. “Institutional theory: Contributing to a theoretical research program”. In Ken G. Smith and Michael A. Hitt (Eds) In Great Minds in Management: The process of Theory Development: 460-484. Oxford: Oxford University Press.
Scott, Richard W. and Gerald F. Davis. 2007. Organizations and organizing: rational, natural, and open system perspectives. N.J: Pearson Prentice Hall
Scott, Richard W. 2008, Institutions and organizations. Thousand Oaks: Sage.
Tassignon, Jean-Pierre. 2006. « The Globalization of Clinical Trials”. Applied Clinical Trials, 15, 1: 42-44.
Theirs, Fabio A, Sinskey, Anthony J, and Berndt, Ernst R, 2008. “Trends in the Globalization of Clinical Trials”. Nature Reviews Drug Discovery, 7, 1: 13-14.
Van Arnum, Patricia. May, 2009. “Taiwan, no longer a life-sciences island unto itself”. Pharmaceutical Technology.com. Advanstar Communications.
Will, Catherine, 2009. “Identifying Effectiveness in ’The Old old’: Principles and Values in the Age of Clinical Trials”. Science, Technology & Human Values. Cambridge, 34, 5: 607
Zuker, L. 1983. “Organizations as institutions”. In S. Bacharach (Ed.), Research in the sociology of organizations: 1-47. Greenwich, CT: JAI Press.
中文期刊與參考書目
周雪光,2003,組織社會學十講,北京:社會科學文獻
吳思華,2000,策略九說:策略思考的本質,台北:臉譜高熏芳、林盈助、王向葵(譯),2001,質化研究設計:一種互動取向的方法Maxwell, Joseph A. 1996. Qualitative Research Design: An Interactive Approach,台北:心理
葉嘉新、林志六(編),2008,新藥開發與臨床試驗,台北:威秀資訊科技
楊玉玲、羅時成,1999,肝炎聖戰:台灣公共衛生史上的大勝利,台北:天下文化
經濟部工業局,2009,生技產業白皮書,經濟部工業局
蕭瑞麟,2006,不用數字的研究:鍛鍊深度思考力的質性研究,台北:培生教育
秦慶瑤,2004,生技產業委外代工的動向與機會,經濟情勢暨評論,9,4: 30-51
莊慧明,2001,生物技術服務業,產業調查與技術季刊,138: 36-51
劉文婷2006,執行高品質的臨床試驗--我們準備好了嗎?,臨床試驗中英文季刊,1: 42-47
邵愛玫,2006,篇名:臺灣臨床試驗嚴重不良事件通報監測機制,臨床試驗中英文季刊,2: 53-58
彭瓊芳,2006,以生物科技產業角度探討疫苗臨床試驗,臨床試驗中英文季刊,3: 15-20
林青青,陶光恆,2006,生技製藥委託研究產業趨勢探討,臨床試驗中英文季刊,3: 9-14
張啟仁,2006,臨床資訊科技操作平臺建置之必要性,臨床試驗中英文季刊,4: 24-31
鮑力恆,2007,臨床試驗研究用藥方面常見之缺失,臨床試驗中英文季刊,4: 32-35
劉仁沛,2007,臨床試驗查核與統計方面缺失,臨床試驗中英文季刊,4: 12-25
何善台,李玉菁,王如娥,2007,臨床試驗查核現況與發展,臨床試驗中英文季刊,4: 2-11
董淑敏,2008,簡介美國之新藥研發關鍵途徑,臨床試驗中英文季刊,3,4: 2-7
王玫,李芝瑩,吳雅琪,林敏雄,2008,近三年查驗中心臨床試驗計劃書統計缺失之分析,臨床試驗中英文季刊,3,4: 41-49
廖宗志,林敏雄,2008,臨床試驗受試者同意書製作注意事項,臨床試驗中英文季刊,3,3: 2-5
陳玲貴,2008,銜接性試驗之法規介紹及現況探討,臨床試驗中英文季刊,3,2 : 2-10
陳瑩如,2008,我國新藥臨床試驗之申請流程及法規要求,臨床試驗中英文季刊,
3,1: 2-13
陳恆德,2006,國內臨床試驗現況簡要問答,財團法人醫藥品查驗中心
行政院衛生署,2006,臨床試驗政策說明,行政院衛生署
秦慶瑤,2007,藥物委外研發及生產趨勢及亞太市場競爭分析,生物技術開發中心ITIS計畫
秦慶瑤,2009,生物技術產業年鑑,生物技術開發中心ITIS計畫